Parallel.

A speech therapist logs on. A district exhales.

Somewhere in one of 25 states, a school clock reads 9:40 a.m. and a third grader who has been waiting months for speech therapy sits down at a laptop. The clinician on the other side of the screen is licensed, vetted, and might live a thousand miles away. That is the ordinary miracle Parallel runs all day: not a robot, not an app pretending to be a therapist, but an actual human specialist piped into a school that could not hire one locally. The district gets to stay on the right side of the law. The kid gets seen.

Parallel - legally Parallel Learning, Inc. - is a special-education company, not an edtech gadget. It contracts directly with public school districts to deliver the services that students' Individualized Education Programs and 504 plans require by law: psychoeducational assessments, speech-language pathology, behavioral and mental-health counseling, and specialized instruction. The twist is the delivery. Everything moves through a proprietary platform that combines secure teletherapy with scheduling, documentation, and clinical oversight.

Roughly one in five kids learns differently. Most schools can't staff for it.

Here is the inconvenient arithmetic of American special education. Federal law guarantees every qualifying student a set of services. The supply of school psychologists, speech-language pathologists, and special-education teachers does not cooperate. Rural districts compete with suburban ones for the same scarce clinicians and lose. Caseloads balloon. Evaluations back up for months. Paperwork eats the hours that were supposed to go to children.

When a district cannot fill an IEP, the consequences land on the student first and the district's legal exposure second. The need does not pause for a hiring cycle. This is the gap Parallel was built to close - not by inventing a new mandate, but by widening the pool of who can fulfill an existing one. If the best available provider for a small-town student happens to live in another time zone, Parallel's answer is: fine, let them work together over video.

Diana Heldfond was diagnosed at seven. She built the company she needed.

Parallel's founder and CEO, Diana Heldfond, does not have to imagine the experience of a kid with learning differences. She was diagnosed with ADHD and dyslexia at age seven, navigated school with them, and went on to study Science, Technology and International Affairs at Georgetown. The company name is the thesis: she frames learning differences not as deficits to be corrected but as parallel ways of thinking to be supported. The branding is sincere, which in this category is rarer than it should be.

Her bet, placed in 2021, was that the painful, expensive, months-long scramble families and schools endure to get a child evaluated and then served could be re-plumbed through a single network of licensed providers and one platform to coordinate them. Investors who do not usually agree on much agreed on this. The Series A in 2022 drew Tiger Global, Obvious Ventures, and Barry Sternlicht's JAWS. Three and a half years later, the Series B brought in Valspring Capital and impact fund Rethink Impact. By December 2025 the company had raised roughly $48.9 million.

Numbers Parallel reports publicly. The company says all 50 states is a two-year goal, not a press-release flourish.

A network of clinicians, wrapped in a platform called Pathway.

Parallel is two things stacked on top of each other. Underneath is a national network of licensed, vetted providers - school psychologists, SLPs, counselors, and specialized instructors. On top is Pathway, the platform that makes the network usable at a district's scale: secure video, scheduling, progress tracking, and the documentation that IDEA-mandated services legally require. Parallel says the system can cut a clinician's prep and paperwork time by as much as 50%, which - if you have ever watched a therapist drown in compliance forms - is the least glamorous and most consequential claim in the whole pitch.

The number that earns the rest of the sentence.

Mission statements are cheap. Outcomes are not. In its 2024-2025 report, Parallel said that 98% of its students met or exceeded their IEP goals - the legally written targets that define whether a service actually worked. It delivered more than 77,000 sessions across 18 states, and logged an average student satisfaction score of 8.9 out of 10. Those are the company's own figures, and a skeptic should hold them as such. But they are specific, goal-anchored, and unusual enough to be worth weighing.

The customers are public school districts, the kind that answer to school boards and auditors rather than venture math. The partnerships lean clinical - assessment publishers like Riverside Insights sit in the toolchain. None of this is consumer-glamorous. All of it is the unglamorous machinery of getting a child the help a court could otherwise compel.

Access is the whole product.

Strip away the platform talk and Parallel is an access company. Its real product is geography defeated: a licensed specialist available to a student who, under the old model, would have joined a waitlist or simply gone without. The competitive field - PresenceLearning, eLuma, TinyEYE, and the traditional staffing agencies - is fighting over the same scarce clinicians and the same overdrawn districts. Parallel's wager is that combining a vetted national network with software that respects the clinician's time wins on both quality and reach.

It is, pleasantly, a business where doing the right thing and doing the scalable thing point in the same direction. The more districts Parallel serves, the more clinicians it can keep busy; the more clinicians, the more students reached. Heldfond's framing - learning differences as parallel, not lesser - is not just marketing decoration. It is the reason the company exists at all.

Back to that clock on the wall.

The clinician shortage is not ending. If anything, the gap between what special-education law promises and what districts can physically staff is widening. That makes the question Parallel is built around less of a startup curiosity and more of a structural one: when the people are not where the need is, how do you connect them without lowering the bar? Parallel's two-year plan to reach all 50 states is a bet that its answer - real clinicians, real oversight, delivered over distance - travels.

So return to the school clock that read 9:40. The third grader finishes the session. The therapist's notes are already filed, because the platform did the filing. The district's compliance is intact, the parent's months of waiting are over, and a kid who learns differently got the exact thing the law said he was owed. Nothing about it looks like a breakthrough. That, quietly, is the point.